IL1B and depressive symptom measurement: Animal research also showed that treatment with agomelatine reversed the signs of anxiety and depression, and decreased the cytokines (tumor necrosis factor-α [TNF-α], interleukin 6 [IL-6], and IL-1β), thiobarbituric acid reactive substances, as well as caspase-3 activity [10].